Objective: The aim of this study was to translate the Psoriasis Disability Index (PDI) into Norwegian and validate it in a Norwegian setting. The PDI is a measure that was developed to assess the impact of psoriasis on the patient's life. Methods: Two hundred and eighty-two patients with psoriasis were included in the study (80% outpatients, and 20% hospitalized). Results: Face and content validity were assessed as satisfactory. The PDI seems to capture issues of importance to patients. The results indicate that the PDI does not capture a unidimensional concept. A factor analysis (principal component with orthogonal rotation) resulted in three factors (physical, social, and hygienic) that were substantially different. All three factors had satisfactory internal consistency. Altogether they explained 58% of the variance. In addition, there were differing patterns of correlations with external criteria, such as dimensions of SF-36, as well as with sex, age, and education. Conclusions: The PDI has been found to have acceptable reliability in this study. However, further validation is necessary to estimate the sensitivity to change.
Introduction
Living with a chronic skin disease such as psoriasis poses problems for the individuals concerned with regard to daily living and functioning [1] [2] [3] . Studies also show that patients with psoriasis rate their general health lower than the general population [4] .
It is important to have valid measures of the concept of disability. Disability can be understood as any restriction or lack of ability to perform an activity in the manner or within the range considered normal for a human being [5] . The reduction of disability due to chronic diseases is one of the main targets of the World Health Organization for health policy in Europe [6] .
Several different methods are available that can be used to describe the burden of illness or the impact on health-related quality of life issues. It is common for investigators to use traditional health status measurement scales to measure health aspects of quality of life. However, the relevance of the domains in generic health status measures varies according to the disease groups studied. Attention is now being paid to disease-specific measures of quality of life which attempt to tap domains that are relevant to people with specific conditions. The study by Bowling [7] has confirmed that the effects of illness on quality of life differ with the patient group and support the trend of developing disease-specific questionnaires in addition to generic scales.
The Psoriasis Disability Index (PDI) is a disease-specific questionnaire measuring disability induced by psoriasis [8] . The PDI is a well-known psoriasis disability measure and has been used in several studies to assess the burden of living with psoriasis, or the effects of different treatments, on patient experience of disability [9] [10] [11] [12] [13] [14] [15] . The questionnaire was developed as a multidimensional measure related to the impact of psoriasis [8] .
The aim of this paper is to report on the validity and reliability tests concerning the Norwegian version of the Psoriasis Disability Index (PDI) for use with Norwegian psoriasis patients. The following questions were asked in this respect:
3. Are the internal consistency of the PDI and its putative subscales satisfactory? 4. Does the PDI show discriminative power (construct validity)?
Methods

Subjects
The sample comprised consecutive inpatients and outpatients treated in three dermatology departments in the eastern part of Norway. Three hundred thirty-four patients were asked to participate in the study. Out of these, 22 patients did not want to participate. Further, 21 patients were excluded because they did not return the questionnaires, and another 9 were excluded because of various problems in completing the questionnaires. Hence, 282 patients completed the testing, yielding a response rate of 85%. Patients filled in the questionnaires at home (except for the hospitalized patients) and sent them back to the researcher. An ethics committee approved the study.
Measures
The following measures were used; The Psoriasis Disability Index (PDI), the Quality of Life Scale (QOLS), and the SF-36. In addition, the degree of physical symptoms specific to psoriasis and sleeping problems were assessed. The QOLS, the SF-36, physical symptoms, and sleeping problems were included to assess aspects of the discriminative power of the PDI. It is quite clear that disease-specific disability, physical symptoms, health status, and overall quality of life are related to each other. However, they are not the same. One could assume that these variables would correlate to a certain extent. Furthermore, demographic variables such as age, gender, marital status, education, and cohabitation, and clinical variables such as hospital setting (in/ outpatients), self-reported arthritis complications (1 item), other chronic diseases (1 item), disease duration, and previous hospitalization, were reported.
Disease-specific Disability: The Psoriasis Disability Index. Comprising 15 questions, the PDI was developed by Finlay and concerns the impact of psoriasis on daily activities, work, personal relationships, leisure, and treatment. Respondents consider the past four weeks, rating questions on a 7-point linear analogue scale on which "0" indicates no disability and "6" represents maximum disability. An overall index of disability is derived, representing the sum of all answers, with scores ranging from 0 to 90. The higher the score, the greater the disability [8, 9] .
The PDI was translated into Norwegian following criteria of translation procedure [16] . First, two independent English-speaking translators translated the questionnaire from English to Norwegian. After an assessment of the Norwegian versions, these were combined into one version by the first author in agreement with the translators. There were only minor discrepancies between the two versions. Thereafter, two other independent translators backtranslated the Norwegian version. The author of the instrument approved the version.
Physical Symptoms Specific to Psoriasis. Selfreported symptoms were assessed in five questions drawn from the literature, concerning symptoms such as itching, burning, scaling, and suppuration, stinging pain and pain in the joints. The response alternatives ranged from no symptoms at all (scored 1) to serious symptoms (scored 7).
Sleep. Sleeping problems were assessed in questions that asked whether the patients experienced their sleep as fitful, had trouble falling asleep, or woke up during their sleeping hours, and how much time it usually took to fall asleep. The index scores ranged from 1 (indicating severe sleeping problems) to 6 (indicating no sleeping problems).
Health Status. The SF-36 is one of several general health status questionnaires developed in the United States by the Medical Outcomes Study (MOS) investigators. It consists of 36 questions on self-reported aspects of health. The instrument includes the following domains: self-reported general health, physical functioning, mental health, bodily pain, role limitations-physical, role limitations-emotional, vitality, social functioning and change in health in the past year. These domains may be combined to form physical and mental health composite scores. The scores are transferred into a scale ranging from 0 to 100. The higher score, the better health. This tool has shown satisfactory reliability and validity, and it has been thoroughly tested for psychometric properties in several countries, including Norway [17] [18] [19] [20] .
Overall Quality of Life. The Quality of Life Scale (QOLS) is a 16-item, domain-specific instrument adapted by Burckhardt et al. [21, 22] for use with patients who have chronic diseases. The questionnaire was developed empirically in the United States by asking people about their quality of life. Rather than employing a theory or model, it explores factors such as physical and material well being, personal development, relationships with others, participation in social, community, and civic activities, and recreation. The questionnaire was developed for a healthy population, then adapted to patients suffering from chronic conditions. Patients were asked to rate their present level of satisfaction with the above-mentioned factors on a 7-point scale called the Delighted-Terrible Scale. The questionnaire is scored by adding up the items to obtain a total score (min. 16 -max. 112). The higher score, the better the quality of life. The QOLS has been validated for use with Norwegian psoriasis patients [23] .
Statistics
The statistical software SPSS PC for Windows (version 7.5) was used in the statistical analyses. Descriptive analyses were performed to assess the frequency, mean (raw and percentage), standard deviation, and range of the scores. Cronbach's alpha was used to estimate the internal consistency of the scale. A principal component analysis with varimax rotation was performed to assess the empirical support of the PDI in a Norwegian sample of patients. Further, correlation coefficient (Pearson's r ), and multiple regression analyses (linear) were used to explore the discriminative power of the PDI. Missing data were handled by giving a missing item the mean score for that item in the total sample if fewer than 40% of the items were missing. Substituting the mean of the completed items in the subscale when more than 50% are completed is generally the most unbiased and precise approach to missing data [24] .
Results
Face and Content Validity of the PDI
Two experts on quality of life in the nursing field and three dermatology nurses assessed the face and content validity of the PDI. Both the experts on the concept of quality of life and the nurses working with the patient group found the instrument to cover important aspects of the impact of living with a disease such as psoriasis. In addition, a sample of 15 patients rated the questionnaire to further secure face validity. This pilot sample was asked to fill in the questionnaire and indicate whether they found the questions relevant to their life situation and easy to answer. None of the patients had difficulty understanding the questions or filling out the responses. They also found the questions relevant to their life situation. Therefore, no corrections or changes were made as a result of these assessments.
Descriptive Information
The demographic and clinical characteristics of the study sample are shown in Table 1 . Eighty percent were attending the outpatient clinics, and 20% were hospitalized. The total mean symptom score was 14.8 (SD 5.8, range 5-33). The patients reported highest score in scaling (mean 3.8, SD 1.6, range 1-7), whereas the patients reported the lowest score with regard to suppuration (mean 1.8, SD 1.4, range 1-7). Further information about the clinical characteristics is shown in Table 1 .
The Kolmogorov-Smirnov Test of normality showed that the PDI in the sample was not normally distributed ( p ϭ .000). The mean total score was 27.7 (SD 19.6, range 0-84). The percentage score was estimated to be 32.9 (SD 23.3). The endorsement frequencies (i.e., less than 85% of respondents providing the same response for each item) for individual items were acceptable in most of the items, except for items 8a and 8b (career affected) and item 13 (unable to use, criticized or stopped from using communal bathing or changing facilities). Respectively, 90, 89, and 87% of the respondents provided "not at all" as a response.
The two most affected areas were the daily activities and treatment domains. The least affected area was work or school for those patients who were employed or attended school. Further descriptive information concerning the Psoriasis Disability Index (PDI) is presented in Table 2 .
Construct Validity
Empirical Support for the PDI Indexes. The construct validity of the PDI was analyzed by means of principal component analyses with orthogonal rotation. The item alternatives 6, 7, and 8 in the questionnaire were combined into one additive index before factor-analyzing the instrument. The principal component analyses using an eigenvalue of Ͼ 1.0 as the criterion resulted in a three-factor solution. The scree plot showed a sharp drop in the percentage of variance explained between the third and fourth factor (Fig. 1) . A three-factor solution was accepted as the best one and was applied to the data. The loading of the PDI items on the three factors is shown in Table 3 .
Thirteen of the original 15 items remained when the criterion of highest loading was used, above 0.35 and at least 0.10 stronger than the next but highest loading. Item 8 (career affected) and item 11 (stopped going out socially or to any special functions) did not fulfill the inclusion criteria. The factors could be labeled as follows:
1. Physical disability (5 items) such as "interfered with carrying out work around the house or garden;" 2. Social disability (4 items) such as "problems with partner or any of your close friends or relatives;" 3. Hygienic disability (4 items) such as "worn different types or colors of clothes because of psoriasis."
The factor solution explained 58% of the total variance in the 15-item PDI. The first author labeled the factors according to the themes of the items. Cronbach's alphas ranged from 0.67 in the social index to 0.88 in the total index (see Table  3 ). Correlation between the three new additive indexes ranged from 0.54 to 0.45. The highest correlation was found between the physical and hygienic indexes. The lowest correlation was found between hygienic and social indexes. Table 3 shows that the squared multiple correlation for each item within each factor ranged from 0.07 to 0.74. In the hygienic factor the lowest correlations were found in item 4 (problem at hairdressers) and in item 2 (worn different types or colors of clothes because of psoriasis), in the social factor item 13 (unable to use, criticized or stopped from using communal bathing or changing facilities) and in item 14 (smoking or drinking alcohol more than normally). With regard to the physical factor, the lowest correlations were found in item 12 (difficult to do any sport) and in item 15 (treatment made your home messy or untidy). None of the squared multiple correlations were above 0.80.
The Discriminative Power of the PDI.
The correlation coefficients between the PDI and the measures of general health status, self-reported symptoms, sleeping problems, hospital setting, and overall quality of life are shown in Table 4 . The results showed that the PDI correlated significantly with all variables in the correlation matrix. Patients who were hospitalized, and patients who reported poorer global quality of life and health, more physical symptoms, and sleeping problems also reported more disability due to the impact of psoriasis.
Results from linear regression analyses, where we looked for interactions, showed main effects (negative) due to education on total disability and in all subdimensions (physical, social, hygienic), indicating that patients with less education report more disability in total and in the subdimensions. Age showed a negative effect on total disability and in the social domain, indicating that younger patients reported more disability both in total and in the social subdomain. A negative effect was seen for sex in the hygienic dimension, indicating that women reported more hygienic disability. As to interactions, age and gender showed negative interaction effects in the hygienic dimension. These results indicate that younger patients and women report more disability in the hygienic dimension. Interaction effects were also found between age and education in the physical dimension (Table 5 ). All independent variables were centered before interaction terms were created. Interaction analyses also showed that when correlation was estimated for three age groups (less than 38, 38-54, more than 54), there was no correlation between education and the physical domain for the oldest patients, but results did show a correlation between education and the social domain in the youngest group. Lastly, the correlation between education and sex, on the one hand, and the hygienic domain, on the other, was much stronger for the oldest patients.
Discussion
As each specialty is asked to prove that their care helps patients, it will become increasingly important to assess the impact of psoriasis on the lives of patients and the ways in which therapy and care improve aspects of their quality of life [25] .
In the present case, a British scale was adapted for use with Norwegian psoriasis patients. Conceptual, semantic, and linguistic divergence may exist between cultures. Success in using a quality of life measure such as the PDI requires a systematic approach to the translation and validation of the measure [16] . The Norwegian version was judged to have satisfactory face validity by nurses in dermatology and by patients suffering from psoriasis. The measure seems to capture important aspects of the lives of psoriasis patients. Further, the content validity was also acceptable from an expert point of view.
Results from both the factor analyses and the discriminative analyses showed that the PDI is not a unidimensional instrument. Regarding the internal consistency of the original scale, the alpha coefficients were satisfactory, which indicates that the scale is an internally consistent, additive in- Three substantively different factors emerged in the Principal Components Analyses. The pool of items in the PDI allows us to create additive indexes with satisfactory internal consistency (reliability) and with intercorrelations between themselves that are only moderately strong. However, three items showed a high endorsement frequency and some of the item-factor squared multiple correlations were low (indicating that they may measure a different construct). Therefore, one could assume that some of these items could be removed. This has to be further investigated. Before items can be removed, the clinical importance of these items has to be judged.
When developing the PDI, the items were grouped into subscales based on common sense. The PDI was not initially subjected to a factor analysis. However, Kent and al Abadie [26] performed a factor analysis on the 15-item version of the PDI with 340 patients with psoriasis and patients with other skin diseases. Although most items on the PDI were specific to psoriasis, some items applied to other skin patient groups. A factor analysis of the items indicated that the PDI contained two subscales, one concerning most aspects of everyday activities, the other concerning specific public situations such as the use of communal facilities. The differences in results from the present factor analyses and the study by Kent and al Abadie [26] could be due to differences in sample characteristics and methods used to investigate the components within the instrument.
The discriminative power of the PDI was supported. Results showed differing patterns of correlation with outside criteria such as the subdimensions of SF-36, hospital setting, symptoms, quality of life, as well as with sex, age, and education. These correlations varied from one subdimension in the PDI to another. The higher level of the PDI scores (more disability) and the lower scores of the SF-36 (less health) were reported. The highest correlation was reported between the PDI and bodily pain and social functioning health scales. Other studies have found similar patterns. Root et al. [12] found that patient-rated severity scores, general health (GHQ), and disability (PDI) were correlated with each other. Finlay [9] found that overall Sickness Impact Profile scores did not coincide with clinical measures of psoriasis severity, but were correlated with the PDI. In a study of 644 patients with mild to moderate psoriasis, Nichol et al. [11] found that the PDI was best correlated with the social functioning scale in the SF-36. Another study showed that the PDI score was highly negatively correlated with all eight of the SF-36 health domains (P Ͻ .0001 for each) [4] . Further, the results from the present study showed that patients who reported a higher level of symptoms (physical impairment) also reported more disability. Results from the study by Root et al. [12] suggests that the impact of the disease will be more closely related to the patient's view of severity than the assessment of disease severity made by doctors. From the patient's point of view, it may be more important to assess the disability effects of the disease than its clinical severity and to institute treatments that are designed to alleviate the social effects of their disease. The PDI also seems to capture differences in age, gender, and educational status. Correlation with demographic variables do not only vary between PDI subdimensions, but associations between the three subdimensions, on the one hand, and sex and education, on the other, are to some extent modified by age (i.e., there are interaction effects).
Descriptive results on the original PDI showed a mean percentage score of 32.9 (SD 23.3), which may be seen as a moderate score. Most disability was connected with daily activities and treatment in this sample. Less disability was reported in the work or school domain. A test of normality showed that the PDI total score was significantly positively skewed, which indicates that the lowest end (low degree of disability) was most used, whereas one would assume the opposite pattern because all the patients were in a disease flare-up state. These results are in accordance with findings in other studies. In a study by Finlay and Coles [10] of the effect of severe psoriasis on the quality of life of 369 patients, the mean PDI percentage score was 38.2 (SD 23.3). The treatment section and the daily activities scored highest, and the personal relationship section scored lowest. In a sample of patients with mild to moderate psoriasis, Nichol et al. [11] found a percentage mean score of 16.59 (SD 16.23).
Conclusion
In summary, the Norwegian version of the PDI has been found to have acceptable reliability and validity for use in this group of Norwegian psoriasis patients. The measure also meets criteria such as brevity, clarity, and ease of administration and coding. The results indicate that the PDI does not capture a unidimensional concept. A factor analy-sis resulted in three factors that were substantially different. In addition, there were differing patterns of correlations with external criteria. However, the scale should be further tested in a sample of patients with less impairment than those in this study to examine the discriminative power of the scale. Further validation within experimental designs is necessary, before it can be claimed that the instrument is sensitive to change.
